Detection of rapidly growing mycobacteria in routine cultures of samples from patients with cystic fibrosis

Journal of Clinical Microbiology

Volumn 49, Issue 4, 2011, Pages 1421-1425

  Esther Jr , Charles R ^a,c   Hoberman, Steven ^b   Fine, Jason ^b   Allen, Sonia ^c   Culbreath, Karissa ^c   Rodino, Kyle ^c   Kerr, Alan ^c   Gilligan, Peter ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID FAST BACTERIUM; AGAR MEDIUM; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA SELECTIVE AGAR; COCULTURE; CONTROLLED STUDY; CORRELATIONAL STUDY; CULTURE MEDIUM; CYSTIC FIBROSIS; HUMAN; HUMAN TISSUE; MYCOBACTERIOSIS; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; RAPIDLY GROWING MYCOBACTERIA; SENSITIVITY ANALYSIS;

BACTERIOLOGICAL TECHNIQUES; CULTURE MEDIA; CYSTIC FIBROSIS; HUMANS; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; SENSITIVITY AND SPECIFICITY;

BACILLI (CLASS); BURKHOLDERIA CEPACIA; CORYNEBACTERINEAE; NEGIBACTERIA;

EID: 79953865307     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02379-10     Document Type: Article

References (15)

1. Colombo, R. E., and K. N. Olivier. 2008. Diagnosis and treatment of infections caused by rapidly growing mycobacteria. Semin. Respir. Crit. Care Med. 29:577-588.
2. Daley, C. L., and D. E. Griffith. 2002. Pulmonary disease caused by rapidly growing mycobacteria. Clin. Chest Med. 23:623-632, vii.
3. Esther, C. R., Jr., D. A. Esserman, P. Gilligan, A. Kerr, and P. G. Noone. 2010. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J. Cyst Fibros. 9:117-123.
4. Esther, C. R., Jr., M. M. Henry, P. L. Molina, and M. W. Leigh. 2005. Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatr. Pulmonol. 40:39-44. (Pubitemid 40917906)
5. Ferroni, A., et al. 2006. Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis. J. Clin. Microbiol. 44:2237-2239. (Pubitemid 43902182)
6. Gilligan, P. H., D. L. Kiska, and M. A. Applebaum. 2006. Cumitech 43, Cystic fibrosis microbiology. ASM Press, Washington, DC.
7. Griffith, D. E., et al. 2007. An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175:367-416.
8. Griffith, D. E., W. M. Girard, and R. J. Wallace, Jr. 1993. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am. Rev. Respir. Dis. 147:1271-1278. (Pubitemid 23149890)
9. Levy, I., et al. 2008. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg. Infect. Dis. 14:378-384. (Pubitemid 351451383)
10. Olivier, K. N. 2004. The natural history of nontuberculous mycobacteria in patients with cystic fibrosis. Paediatr. Respir. Rev. 5(Suppl. A):S213-S216.
11. Olivier, K. N., et al. 2003. Nontuberculous mycobacteria. II. Nested-cohort study of impact on cystic fibrosis lung disease. Am. J. Respir. Crit. Care Med. 167:835-840. (Pubitemid 36801770)
12. Olivier, K. N., et al. 2003. Nontuberculous mycobacteria. I. Multicenter prevalence study in cystic fibrosis. Am. J. Respir. Crit. Care Med. 167:828-834. (Pubitemid 36801769)
13. Saiman, L., et al. 2003. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: A randomized controlled trial. JAMA 290:1749-1756. (Pubitemid 37430625)
14. Saiman, L., and J. Siegel. 2003. Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect. Control Hosp. Epidemiol. 24:S6-S52. (Pubitemid 36617275)
15. Whittier, S., K. Olivier, P. Gilligan, M. Knowles, and P. Della-Latta. 1997. Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. J. Clin. Microbiol. 35:2706-2708. (Pubitemid 27402696)